FFPE Tissue Samples Market: Introduction
According to the report, the global FFPE tissue samples market was valued over US$ 1.64 Bn in 2024, and it is projected to expand at a CAGR of 4.8% from 2024 to 2031. FFPE is a form of preparation and preservation for biopsy specimens, which helps in diagnostic/drug development, experimental research, and examination.
A tissue sample is first fixed in formalin, also known as formaldehyde, to preserve vital structures and the proteins within the tissue. Subsequently, the tissue is embedded in a paraffin wax block; this helps for examination under a microscope. The global FFPE tissue samples market is expected to be driven by the expansion of the pharmaceutical sector during the forecast period.
North America held a major share of the global FFPE tissue samples market in 2024, due to high demand for FFPE tissue samples in the region. Additionally, technological advancements drive the demand for FFPE tissue samples, which is expected to augment the market in the region.
The FFPE tissue samples market in Asia Pacific is likely to expand at a high CAGR of 5.35% from 2024 to 2031 due to an increase in prevalence and incidence of chronic diseases such as cancer.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=78463
Proteomic Study & Analysis to Offer Lucrative Opportunities
In terms of application, the global FFPE tissue samples market has been classified into genomic study & analysis and proteomic study & analysis. The proteomic study & analysis segment dominated the global FFPE tissue samples market in 2024, and the trend is projected to continue during the forecast period. The genomic study & analysis segment has been split into whole genome sequencing & amplification, next generation sequencing, and DNA Extraction. The proteomic study & analysis segment has been segregated into protein extraction and clinical proteomics.
FFPE Diseased Tissue Samples Held Major Share of FFPE Tissue Samples Market
Based on tissue sample type, the global FFPE tissue samples market has been categorized into FFPE normal tissue samples and FFPE diseased tissue samples. The FFPE diseased tissue samples segment held a major share of the global FFPE tissue samples market in 2024. Increase in prevalence and incidence of cancer drives the segment.
Request for Analysis of COVID-19 Impact on FFPE Tissue Samples Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=78463
Research & Scientific Laboratories to be Highly Promising End Users
In terms of end user, the global FFPE tissue samples market has been divided into research & scientific laboratories, diagnostic laboratories, and specialized clinics. The research & scientific laboratories segment held a major share of the global FFPE tissue samples market in 2024.
North America to Dominate Global Market; Asia Pacific to Offer Significant Opportunities
In terms of region, the global FFPE tissue samples market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is anticipated to account for a leading share of the global FFPE tissue samples market during the forecast period. The FFPE tissue samples market in Asia Pacific is projected to expand at a rapid pace in the near future. India and China are likely to be lucrative markets for FFPE tissue samples during the forecast period.
Pre Book FFPE Tissue Samples Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=78463<ype=S
Growth Strategies of Key Players
Key players operating in the global FFPE tissue samples market are AMSBIO, BioChain Institute, Inc., Cureline, Discovery Life Sciences, Geneticist, Inc., Lab-Ally, Merck KGaA, OriGene Technologies, Inc., PrecisionMed, Inc., Pressure BioSciences, Inc., ProteoGenex, REPROCELL, Inc., and TriStar Technology Group LLC. These companies engage in the development of FFPE tissue samples in order to expand product offerings and customer base.
More Trending Reports by Transparency Market Research –
Cellular Health Screening Market: https://www.biospace.com/article/cellular-health-screening-market-telomere-tests-likely-to-remain-dominant-test-type-/
Clinical Decision Support System Market: https://www.biospace.com/article/clinical-decision-support-system-market-cloud-based-clinical-decision-support-system-is-estimated-to-grow-at-exponential-growth-rate/
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
